The molecular details of coeliac disease
01 May, 2014Australian, US and Dutch researchers have determined the molecular details of the interaction between the immune system and gluten that triggers coeliac disease.
Starpharma tech applied to AstraZeneca cancer drug
08 April, 2014Melbourne-based biotech company Starpharma has signed an expanded agreement with biopharma company AstraZeneca in the field of cancer medicine. The new agreement will see the application of Starpharma's dendrimer technology to a cancer drug from AstraZeneca's pipeline.
Diagnostic device meets malaria field evaluation objective
25 March, 2014Fio Corporation's Deki Reader - a mobile in vitro diagnostic device - has demonstrated consistent interpretation of rapid diagnostic tests (RDTs) for multiple malaria strains in a field evaluation.
Turning the spotlight on breast cancer cells
20 March, 2014Scientists are using the latest in nano-flare technology to detect breast cancer cells early on.
Drug testing with synthetic livers
19 March, 2014Scientists from clinical intelligence company Empiriko have developed chemosynthetic liver technology which could enable the testing of drug candidates without using animals.
Biomarkers reveal short-term risk of death
05 March, 2014Researchers from Finland and Estonia have discovered novel biological markers that indicate an individual's risk of dying from any disease in the near future.
Successful phase 2 results in Huntington disease trial
24 February, 2014Prana Biotechnology has announced the results of its phase 2 clinical trial investigating the drug PBT2 as a treatment for Huntington disease.
€85 million to fight Gram-negative pathogens
13 February, 2014Over 30 European universities, research institutes and companies are joining forces in a six-year, €85 million program to develop novel antibiotics against Gram-negative pathogens.
What killed Knut, Berlin Zoo's polar bear?
07 February, 2014After one of the most intensive investigations in veterinary history for a single animal, what caused the death of Berlin Zoological Garden's polar bear, Knut, has been revealed.
Developing single-dose vaccines for cattle
06 February, 2014Researchers at The University of Queensland (UQ) are working on a single-dose (shelf-stable) vaccine that could be used to prevent common cattle diseases and reduce vaccination costs.
Identifying staph with a beacon, not a biopsy
04 February, 2014Researchers at the University of Iowa (UI) have created a probe that can detect a common strain of staph bacteria (Staphylococcus aureus) in the body. Their method has been published in the journal Nature Medicine.
Positive phase 1 results for Admedus herpes trial
03 February, 2014Healthcare company Admedus today announced interim study results on its phase 1 trial of a therapeutic vaccine for herpes simplex virus (HSV-2). The vaccine was found to be safe in the study subjects and was able to generate a T-cell response.
Modelling ovarian cancer
29 January, 2014Scientists at Queensland University of Technology (QUT), funded by Cancer Council Queensland, are conducting research into the deadliest form of ovarian cancer.
Non-invasive, risk-free screen for Down syndrome
13 January, 2014Researchers at Curtin University have assessed the use of a new non-invasive prenatal testing (NIPT) technique to identify Down syndrome in foetuses.
HPV testing at home
09 January, 2014A Lund University study has found that HPV self-testing is as effective as tests done by doctors and, more importantly, more comfortable for women who find regular smear tests unpleasant.
